Lynx Investment Advisory’s CME Group CME Stock Holding History

Lynx Investment Advisory’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11	Closed	-$2.16K	–	255
2024 Q2	$2.16K	Buy	+11	New	+$2.27K	﹤0.01%	563

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lynx Investment Advisory's CME Position: Q3 2024 in Review

Lynx Investment Advisory sold out of CME Group (CME) in Q3 2024, closing a stake of 11 shares — an estimated $2.16K sold.

Lynx Investment Advisory first reported a position in CME in Q2 2024 and held it in 1 quarter. The position peaked at $2.16K in Q2 2024. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

Lynx Investment Advisory reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
Lynx Investment Advisory sold 11 CME Group shares in Q3 2024, an estimated $2.16K.
Lynx Investment Advisory first reported a position in CME Group in Q2 2024 and held it in 1 quarter.
Lynx Investment Advisory's CME Group position peaked at $2.16K in Q2 2024.
1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on Lynx Investment Advisory's 13F filing for Q3 2024, filed 4 Nov 2024.